|
|
regulation of organ growth
|
GO:0046620 |
3 |
0.541
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
216 |
0.453
|
|
|
|
vasculature development
|
GO:0001944 |
278 |
0.361
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
274 |
0.275
|
|
|
|
gastrulation
|
GO:0007369 |
208 |
0.249
|
|
|
|
ossification
|
GO:0001503 |
23 |
0.222
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
3 |
0.207
|
|
|
|
segmentation
|
GO:0035282 |
97 |
0.195
|
|
|
|
somite development
|
GO:0061053 |
96 |
0.187
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
39 |
0.182
|
|
|
|
regionalization
|
GO:0003002 |
274 |
0.170
|
|
|
|
response to drug
|
GO:0042493 |
3 |
0.164
|
|
|
|
determination of dorsal identity
|
GO:0048263 |
13 |
0.161
|
|
|
|
regulation of protein binding
|
GO:0043393 |
3 |
0.134
|
|
|
|
blood vessel development
|
GO:0001568 |
246 |
0.133
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.132
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
2 |
0.128
|
|
|
|
somitogenesis
|
GO:0001756 |
87 |
0.125
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001240 |
1 |
0.124
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
53 |
0.124
|
|
|
|
cellular component movement
|
GO:0006928 |
335 |
0.121
|
|
|
|
single organism organelle organization
|
GO:1902589 |
199 |
0.119
|
|
|
|
cell chemotaxis
|
GO:0060326 |
17 |
0.115
|
|
|
|
regulation of gene expression
|
GO:0010468 |
265 |
0.114
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
3 |
0.113
|
|
|
|
localization of cell
|
GO:0051674 |
244 |
0.113
|
|
|
|
digestive tract development
|
GO:0048565 |
265 |
0.109
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
139 |
0.106
|
|
|
|
lymphoid lineage cell migration into thymus
|
GO:0097535 |
4 |
0.104
|
|
|
|
muscle tissue development
|
GO:0060537 |
110 |
0.103
|
|
|
|
regulation of heart growth
|
GO:0060420 |
2 |
0.103
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
3 |
0.097
|
|
|
|
pathway restricted smad protein phosphorylation
|
GO:0060389 |
1 |
0.096
|
|
|
|
cardiac atrium development
|
GO:0003230 |
4 |
0.094
|
|
|
|
vasculogenesis
|
GO:0001570 |
41 |
0.092
|
|
|
|
cardiac atrium morphogenesis
|
GO:0003209 |
2 |
0.091
|
|
|
|
positive regulation of axon guidance
|
GO:1902669 |
1 |
0.088
|
|
|
|
regulation of oxidative stress induced cell death
|
GO:1903201 |
2 |
0.085
|
|
|
|
epithelial cell migration
|
GO:0010631 |
25 |
0.084
|
|
|
|
stem cell maintenance
|
GO:0019827 |
4 |
0.084
|
|
|
|
regulation of biological quality
|
GO:0065008 |
263 |
0.082
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
1 |
0.077
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
4 |
0.076
|
|
|
|
cell motility
|
GO:0048870 |
244 |
0.076
|
|
|
|
positive regulation of muscle organ development
|
GO:0048636 |
1 |
0.072
|
|
|
|
patterning of blood vessels
|
GO:0001569 |
15 |
0.071
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
57 |
0.067
|
|
|
|
digestive system development
|
GO:0055123 |
289 |
0.065
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
2 |
0.064
|
|
|
|
negative regulation of cellular process
|
GO:0048523 |
283 |
0.064
|
|
|
|
facial nerve development
|
GO:0021561 |
3 |
0.064
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.063
|
|
|
|
regulation of response to stimulus
|
GO:0048583 |
269 |
0.063
|
|
|
|
retina vasculature development in camera type eye
|
GO:0061298 |
2 |
0.062
|
|
|
|
skeletal system development
|
GO:0001501 |
181 |
0.062
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
3 |
0.061
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
178 |
0.061
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
1 |
0.059
|
|
|
|
cognition
|
GO:0050890 |
1 |
0.059
|
|
|
|
stem cell differentiation
|
GO:0048863 |
117 |
0.059
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
2 |
0.058
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
3 |
0.057
|
|
|
|
mesenchyme development
|
GO:0060485 |
127 |
0.056
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
1 |
0.055
|
|
|
|
heart development
|
GO:0007507 |
313 |
0.055
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
32 |
0.055
|
|
|
|
muscle structure development
|
GO:0061061 |
196 |
0.055
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
2 |
0.054
|
|
|
|
regulation of cell communication
|
GO:0010646 |
232 |
0.052
|
|
|
|
cellular response to radiation
|
GO:0071478 |
4 |
0.051
|
|
|
|
tube morphogenesis
|
GO:0035239 |
349 |
0.050
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
1 |
0.049
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
33 |
0.049
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
65 |
0.049
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
110 |
0.048
|
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
2 |
0.048
|
|
|
|
negative regulation of signal transduction in absence of ligand
|
GO:1901099 |
1 |
0.048
|
|
|
|
regulation of type b pancreatic cell proliferation
|
GO:0061469 |
1 |
0.047
|
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
2 |
0.046
|
|
|
|
angiogenesis
|
GO:0001525 |
158 |
0.046
|
|
|
|
regulation of binding
|
GO:0051098 |
3 |
0.046
|
|
|
|
chordate embryonic development
|
GO:0043009 |
271 |
0.046
|
|
|
|
stem cell development
|
GO:0048864 |
82 |
0.046
|
|
|
|
aging
|
GO:0007568 |
2 |
0.045
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
13 |
0.044
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
98 |
0.044
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
1 |
0.044
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
148 |
0.043
|
|
|
|
positive regulation of striated muscle tissue development
|
GO:0045844 |
1 |
0.043
|
|
|
|
organelle organization
|
GO:0006996 |
227 |
0.042
|
|
|
|
striated muscle cell development
|
GO:0055002 |
108 |
0.042
|
|
|
|
endodermal cell fate commitment
|
GO:0001711 |
18 |
0.042
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
98 |
0.041
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
2 |
0.041
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
3 |
0.040
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
3 |
0.040
|
|
|
|
lymph vessel development
|
GO:0001945 |
27 |
0.039
|
|
|
|
regulation of developmental process
|
GO:0050793 |
247 |
0.039
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
2 |
0.038
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
6 |
0.038
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
4 |
0.038
|
|
|
|
heart morphogenesis
|
GO:0003007 |
156 |
0.038
|
|
|
|
endodermal cell differentiation
|
GO:0035987 |
19 |
0.038
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
26 |
0.037
|
|
|
|
liver development
|
GO:0001889 |
96 |
0.037
|
|
|
|
tissue migration
|
GO:0090130 |
37 |
0.036
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
52 |
0.036
|
|
|
|
sensory organ development
|
GO:0007423 |
393 |
0.036
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.036
|
|
|
|
lymphoid lineage cell migration
|
GO:0097534 |
4 |
0.036
|
|
|
|
negative regulation of axon regeneration
|
GO:0048681 |
4 |
0.036
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
143 |
0.035
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
35 |
0.035
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
1 |
0.034
|
|
|
|
endoderm formation
|
GO:0001706 |
29 |
0.034
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
4 |
0.034
|
|
|
|
regulation of jun kinase activity
|
GO:0043506 |
3 |
0.034
|
|
|
|
renal system development
|
GO:0072001 |
94 |
0.033
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
1 |
0.033
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
1 |
0.033
|
|
|
|
neuron projection development
|
GO:0031175 |
180 |
0.033
|
|
|
|
embryonic organ development
|
GO:0048568 |
381 |
0.032
|
|
|
|
biological adhesion
|
GO:0022610 |
40 |
0.032
|
|
|
|
negative regulation of biological process
|
GO:0048519 |
304 |
0.032
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
62 |
0.032
|
|
|
|
eye development
|
GO:0001654 |
277 |
0.032
|
|
|
|
negative regulation of calcium dependent cell cell adhesion
|
GO:0046588 |
1 |
0.032
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
1 |
0.031
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
0 |
0.031
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
114 |
0.031
|
|
|
|
venous blood vessel development
|
GO:0060841 |
9 |
0.031
|
|
|
|
actin filament based process
|
GO:0030029 |
64 |
0.031
|
|
|
|
venous blood vessel morphogenesis
|
GO:0048845 |
3 |
0.031
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
1 |
0.031
|
|
|
|
cellular component assembly
|
GO:0022607 |
170 |
0.031
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
12 |
0.030
|
|
|
|
regulation of response to oxidative stress
|
GO:1902882 |
2 |
0.030
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
2 |
0.030
|
|
|
|
determination of left right asymmetry in lateral mesoderm
|
GO:0003140 |
20 |
0.030
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
333 |
0.030
|
|
|
|
signal transduction
|
GO:0007165 |
455 |
0.030
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
1 |
0.029
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
2 |
0.029
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
4 |
0.029
|
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
4 |
0.029
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
1 |
0.029
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
1 |
0.029
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
1 |
0.029
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
1 |
0.028
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
71 |
0.028
|
|
|
|
organelle assembly
|
GO:0070925 |
110 |
0.028
|
|
|
|
germ line stem cell maintenance
|
GO:0030718 |
2 |
0.027
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
29 |
0.027
|
|
|
|
tissue regeneration
|
GO:0042246 |
74 |
0.027
|
|
|
|
cell adhesion
|
GO:0007155 |
40 |
0.027
|
|
|
|
cell morphogenesis
|
GO:0000902 |
289 |
0.027
|
|
|
|
regulation of response to cytokine stimulus
|
GO:0060759 |
3 |
0.027
|
|
|
|
cellular macromolecule metabolic process
|
GO:0044260 |
391 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
3 |
0.026
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
69 |
0.026
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
223 |
0.026
|
|
|
|
cellular response to xenobiotic stimulus
|
GO:0071466 |
35 |
0.026
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
53 |
0.026
|
|
|
|
blood vessel endothelial cell proliferation involved in sprouting angiogenesis
|
GO:0002043 |
4 |
0.026
|
|
|
|
endothelial cell migration
|
GO:0043542 |
19 |
0.026
|
|
|
|
amine metabolic process
|
GO:0009308 |
2 |
0.026
|
|
|
|
mesoderm formation
|
GO:0001707 |
43 |
0.026
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.026
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
2 |
0.026
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
1 |
0.026
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
50 |
0.025
|
|
|
|
regulation of cell shape
|
GO:0008360 |
1 |
0.025
|
|
|
|
regulation of signaling
|
GO:0023051 |
235 |
0.024
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
4 |
0.024
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
1 |
0.024
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
4 |
0.024
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
11 |
0.024
|
|
|
|
determination of dorsal ventral asymmetry
|
GO:0048262 |
34 |
0.024
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
22 |
0.024
|
|
|
|
cardiac chamber development
|
GO:0003205 |
19 |
0.024
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
1 |
0.024
|
|
|
|
cartilage development
|
GO:0051216 |
96 |
0.024
|
|
|
|
regulation of protein transport
|
GO:0051223 |
3 |
0.024
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
46 |
0.023
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
12 |
0.023
|
|
|
|
activation of jun kinase activity
|
GO:0007257 |
2 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
87 |
0.023
|
|
|
|
dorsal convergence
|
GO:0060030 |
14 |
0.023
|
|
|
|
cardiac conduction system development
|
GO:0003161 |
1 |
0.023
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
3 |
0.023
|
|
|
|
heart looping
|
GO:0001947 |
94 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
92 |
0.023
|
|
|
|
wound healing
|
GO:0042060 |
90 |
0.022
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
85 |
0.022
|
|
|
|
regulation of cell death
|
GO:0010941 |
103 |
0.022
|
|
|
|
positive regulation of endothelial cell proliferation
|
GO:0001938 |
1 |
0.022
|
|
|
|
muscle organ development
|
GO:0007517 |
101 |
0.022
|
|
|
|
osteoclast development
|
GO:0036035 |
1 |
0.022
|
|
|
|
regulation of cell motility
|
GO:2000145 |
46 |
0.022
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
122 |
0.022
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
1 |
0.022
|
|
|
|
urogenital system development
|
GO:0001655 |
97 |
0.022
|
|
|
|
trabecula formation
|
GO:0060343 |
2 |
0.021
|
|
|
|
nucleic acid metabolic process
|
GO:0090304 |
244 |
0.021
|
|
|
|
negative regulation of response to cytokine stimulus
|
GO:0060761 |
2 |
0.021
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
72 |
0.021
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
2 |
0.021
|
|
|
|
innervation
|
GO:0060384 |
3 |
0.021
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
1 |
0.021
|
|
|
|
water transport
|
GO:0006833 |
15 |
0.021
|
|
|
|
cellular response to reactive oxygen species
|
GO:0034614 |
2 |
0.021
|
|
|
|
neurological system process
|
GO:0050877 |
62 |
0.021
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
142 |
0.021
|
|
|
|
negative regulation of rna biosynthetic process
|
GO:1902679 |
45 |
0.021
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
1 |
0.020
|
|
|
|
negative regulation of non canonical wnt signaling pathway
|
GO:2000051 |
1 |
0.020
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
55 |
0.020
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
31 |
0.020
|
|
|
|
collagen fibril organization
|
GO:0030199 |
1 |
0.020
|
|
|
|
locomotion
|
GO:0040011 |
313 |
0.020
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
1 |
0.020
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
2 |
0.020
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
2 |
0.020
|
|
|
|
macromolecule modification
|
GO:0043412 |
111 |
0.020
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
68 |
0.020
|
|
|
|
cell migration
|
GO:0016477 |
237 |
0.020
|
|
|
|
response to fatty acid
|
GO:0070542 |
5 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
2 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
35 |
0.019
|
|
|
|
positive regulation of axon extension involved in axon guidance
|
GO:0048842 |
1 |
0.019
|
|
|
|
cell surface receptor signaling pathway
|
GO:0007166 |
325 |
0.019
|
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
3 |
0.019
|
|
|
|
heterocycle biosynthetic process
|
GO:0018130 |
215 |
0.019
|
|
|
|
nuclear import
|
GO:0051170 |
3 |
0.019
|
|
|
|
notochord morphogenesis
|
GO:0048570 |
17 |
0.019
|
|
|
|
cell migration involved in sprouting angiogenesis
|
GO:0002042 |
8 |
0.019
|
|
|
|
developmental growth
|
GO:0048589 |
166 |
0.019
|
|
|
|
regulation of cellular extravasation
|
GO:0002691 |
1 |
0.019
|
|
|
|
positive regulation of leukocyte migration
|
GO:0002687 |
2 |
0.019
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
17 |
0.019
|
|
|
|
tissue remodeling
|
GO:0048771 |
4 |
0.019
|
|
|
|
connective tissue development
|
GO:0061448 |
99 |
0.019
|
|
|
|
cardiac cell fate commitment
|
GO:0060911 |
1 |
0.019
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
4 |
0.019
|
|
|
|
negative regulation of neutrophil chemotaxis
|
GO:0090024 |
3 |
0.019
|
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
1 |
0.019
|
|
|
|
circulatory system process
|
GO:0003013 |
87 |
0.019
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
2 |
0.018
|
|
|
|
regulation of tube size
|
GO:0035150 |
2 |
0.018
|
|
|
|
cellular biosynthetic process
|
GO:0044249 |
286 |
0.018
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
152 |
0.018
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
79 |
0.018
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
1 |
0.018
|
|
|
|
macrophage chemotaxis
|
GO:0048246 |
3 |
0.018
|
|
|
|
female gonad development
|
GO:0008585 |
4 |
0.018
|
|
|
|
muscle cell development
|
GO:0055001 |
115 |
0.018
|
|
|
|
water homeostasis
|
GO:0030104 |
4 |
0.018
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
7 |
0.018
|
|
|
|
regulation of gastrulation
|
GO:0010470 |
24 |
0.018
|
|
|
|
glomerulus development
|
GO:0032835 |
27 |
0.018
|
|
|
|
heterophilic cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0007157 |
2 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
3 |
0.018
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
8 |
0.017
|
|
|
|
positive regulation of epithelial cell differentiation
|
GO:0030858 |
2 |
0.017
|
|
|
|
regulation of wnt signaling pathway planar cell polarity pathway
|
GO:2000095 |
2 |
0.017
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
4 |
0.017
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
0 |
0.017
|
|
|
|
oocyte maturation
|
GO:0001556 |
4 |
0.017
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
4 |
0.017
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
22 |
0.017
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
90 |
0.017
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
2 |
0.017
|
|
|
|
angioblast cell migration involved in selective angioblast sprouting
|
GO:0035475 |
4 |
0.017
|
|
|
|
negative regulation of axon extension involved in axon guidance
|
GO:0048843 |
1 |
0.017
|
|
|
|
nitrogen compound metabolic process
|
GO:0006807 |
319 |
0.017
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
4 |
0.017
|
|
|
|
endocardial cushion formation
|
GO:0003272 |
2 |
0.017
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
56 |
0.017
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
1 |
0.017
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
1 |
0.017
|
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
74 |
0.017
|
|
|
|
regulation of locomotion
|
GO:0040012 |
55 |
0.017
|
|
|
|
rna metabolic process
|
GO:0016070 |
219 |
0.017
|
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
2 |
0.017
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
2 |
0.017
|
|
|
|
protein complex subunit organization
|
GO:0071822 |
46 |
0.017
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
21 |
0.017
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
129 |
0.017
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
4 |
0.017
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
69 |
0.017
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
231 |
0.017
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
1 |
0.017
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
2 |
0.017
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
4 |
0.017
|
|
|
|
endocrine process
|
GO:0050886 |
2 |
0.017
|
|
|
|
regulation of dna replication
|
GO:0006275 |
3 |
0.016
|
|
|
|
appendage development
|
GO:0048736 |
80 |
0.016
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
3 |
0.016
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
15 |
0.016
|
|
|
|
nuclear transport
|
GO:0051169 |
4 |
0.016
|
|
|
|
response to fluid shear stress
|
GO:0034405 |
2 |
0.016
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
4 |
0.016
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
4 |
0.016
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
93 |
0.016
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
3 |
0.016
|
|
|
|
venous endothelial cell migration involved in lymph vessel development
|
GO:0060855 |
4 |
0.016
|
|
|
|
cellular protein metabolic process
|
GO:0044267 |
129 |
0.016
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
1 |
0.016
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
3 |
0.016
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
2 |
0.016
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
1 |
0.016
|
|
|
|
ear development
|
GO:0043583 |
127 |
0.016
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
4 |
0.016
|
|
|
|
regulation of myotube differentiation
|
GO:0010830 |
2 |
0.016
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
2 |
0.016
|
|
|
|
regulation of wnt signaling pathway involved in digestive tract morphogenesis
|
GO:2000056 |
2 |
0.015
|
|
|
|
biomineral tissue development
|
GO:0031214 |
13 |
0.015
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
336 |
0.015
|
|
|
|
glomerulus vasculature development
|
GO:0072012 |
2 |
0.015
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
3 |
0.015
|
|
|
|
organic cyclic compound metabolic process
|
GO:1901360 |
301 |
0.015
|
|
|
|
locomotor rhythm
|
GO:0045475 |
3 |
0.015
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
7 |
0.015
|
|
|
|
response to wounding
|
GO:0009611 |
116 |
0.015
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
2 |
0.015
|
|
|
|
regulation of mononuclear cell migration
|
GO:0071675 |
1 |
0.015
|
|
|
|
regulation of cardiac muscle cell differentiation
|
GO:2000725 |
1 |
0.015
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
47 |
0.015
|
|
|
|
post embryonic organ development
|
GO:0048569 |
4 |
0.015
|
|
|
|
endocardial cushion morphogenesis
|
GO:0003203 |
3 |
0.015
|
|
|
|
response to ketone
|
GO:1901654 |
1 |
0.015
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
2 |
0.014
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
3 |
0.014
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
2 |
0.014
|
|
|
|
cellular response to starvation
|
GO:0009267 |
1 |
0.014
|
|
|
|
negative regulation of collateral sprouting
|
GO:0048671 |
2 |
0.014
|
|
|
|
synapse organization
|
GO:0050808 |
21 |
0.014
|
|
|
|
phagocytosis
|
GO:0006909 |
3 |
0.014
|
|
|
|
regulation of meiotic cell cycle
|
GO:0051445 |
1 |
0.014
|
|
|
|
cellular nitrogen compound metabolic process
|
GO:0034641 |
290 |
0.014
|
|
|
|
mononuclear cell migration
|
GO:0071674 |
1 |
0.014
|
|
|
|
hypochord development
|
GO:0055016 |
3 |
0.014
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
57 |
0.014
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
108 |
0.014
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
101 |
0.014
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
4 |
0.014
|
|
|
|
death
|
GO:0016265 |
121 |
0.014
|
|
|
|
centrosome organization
|
GO:0051297 |
1 |
0.014
|
|
|
|
response to stress
|
GO:0006950 |
263 |
0.014
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
94 |
0.014
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
4 |
0.014
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
17 |
0.014
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
2 |
0.014
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
0 |
0.014
|
|
|
|
carbon dioxide transport
|
GO:0015670 |
3 |
0.014
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.014
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
80 |
0.014
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
106 |
0.013
|
|
|
|
regulation of positive chemotaxis
|
GO:0050926 |
4 |
0.013
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
2 |
0.013
|
|
|
|
organic substance biosynthetic process
|
GO:1901576 |
289 |
0.013
|
|
|
|
negative regulation of cellular macromolecule biosynthetic process
|
GO:2000113 |
48 |
0.013
|
|
|
|
hormone secretion
|
GO:0046879 |
2 |
0.013
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
4 |
0.013
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
48 |
0.013
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
107 |
0.013
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
225 |
0.013
|
|
|
|
cell projection organization
|
GO:0030030 |
284 |
0.013
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
0 |
0.013
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
4 |
0.013
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
2 |
0.013
|
|
|
|
neural crest formation
|
GO:0014029 |
14 |
0.013
|
|
|
|
neural crest cell migration
|
GO:0001755 |
42 |
0.013
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
39 |
0.013
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.013
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
77 |
0.013
|
|
|
|
negative regulation of leukocyte chemotaxis
|
GO:0002689 |
3 |
0.012
|
|
|
|
response to nutrient
|
GO:0007584 |
3 |
0.012
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
1 |
0.012
|
|
|
|
regulation of system process
|
GO:0044057 |
40 |
0.012
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
78 |
0.012
|
|
|
|
aromatic compound biosynthetic process
|
GO:0019438 |
217 |
0.012
|
|
|
|
collateral sprouting in absence of injury
|
GO:0048669 |
4 |
0.012
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
3 |
0.012
|
|
|
|
heart jogging
|
GO:0003146 |
40 |
0.012
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
63 |
0.012
|
|
|
|
response to corticosteroid
|
GO:0031960 |
1 |
0.012
|
|
|
|
larval heart development
|
GO:0007508 |
2 |
0.012
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
1 |
0.012
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
55 |
0.012
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
2 |
0.012
|
|
|
|
heart contraction
|
GO:0060047 |
71 |
0.012
|
|
|
|
endothelium development
|
GO:0003158 |
25 |
0.012
|
|
|
|
neural crest cell development
|
GO:0014032 |
62 |
0.012
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
57 |
0.012
|
|
|
|
cell projection assembly
|
GO:0030031 |
64 |
0.012
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
56 |
0.012
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
4 |
0.012
|
|
|
|
single organism metabolic process
|
GO:0044710 |
217 |
0.012
|
|
|
|
regulation of biosynthetic process
|
GO:0009889 |
250 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
1 |
0.012
|
|
|
|
septum transversum development
|
GO:0003343 |
4 |
0.012
|
|
|
|
cell death
|
GO:0008219 |
121 |
0.012
|
|
|
|
protein metabolic process
|
GO:0019538 |
183 |
0.012
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
87 |
0.012
|
|
|
|
regulation of dendrite development
|
GO:0050773 |
3 |
0.012
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
4 |
0.012
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
57 |
0.012
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
1 |
0.011
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
1 |
0.011
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
96 |
0.011
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
2 |
0.011
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
102 |
0.011
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
1 |
0.011
|
|
|
|
regulation of rna metabolic process
|
GO:0051252 |
224 |
0.011
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
42 |
0.011
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
30 |
0.011
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
35 |
0.011
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
97 |
0.011
|
|
|
|
cellular nitrogen compound biosynthetic process
|
GO:0044271 |
218 |
0.011
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
20 |
0.011
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
15 |
0.011
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
130 |
0.011
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
18 |
0.011
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
3 |
0.011
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
59 |
0.011
|
|
|
|
response to oxygen levels
|
GO:0070482 |
25 |
0.011
|
|
|
|
regulation of neurotransmitter secretion
|
GO:0046928 |
1 |
0.011
|
|
|
|
synaptic growth at neuromuscular junction
|
GO:0051124 |
2 |
0.011
|
|
|
|
endoderm development
|
GO:0007492 |
49 |
0.011
|
|
|
|
single organism localization
|
GO:1902578 |
225 |
0.011
|
|
|
|
negative regulation of cell cell adhesion
|
GO:0022408 |
6 |
0.011
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
3 |
0.011
|
|
|
|
secondary metabolic process
|
GO:0019748 |
3 |
0.011
|
|
|
|
response to prostaglandin
|
GO:0034694 |
5 |
0.011
|
|
|
|
response to oxygen radical
|
GO:0000305 |
2 |
0.011
|
|
|
|
spindle assembly
|
GO:0051225 |
2 |
0.011
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
2 |
0.011
|
|
|
|
regulation of vasculogenesis
|
GO:2001212 |
1 |
0.011
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
7 |
0.011
|
|
|
|
positive regulation of positive chemotaxis
|
GO:0050927 |
4 |
0.011
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
3 |
0.011
|
|
|
|
lipid homeostasis
|
GO:0055088 |
3 |
0.011
|
|
|
|
wnt signaling pathway planar cell polarity pathway
|
GO:0060071 |
4 |
0.011
|
|
|
|
microglia differentiation
|
GO:0014004 |
1 |
0.011
|
|
|
|
hormone transport
|
GO:0009914 |
2 |
0.010
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
17 |
0.010
|
|
|
|
activation of mapk activity
|
GO:0000187 |
3 |
0.010
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
3 |
0.010
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
2 |
0.010
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
125 |
0.010
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
1 |
0.010
|
|
|
|
neuron development
|
GO:0048666 |
262 |
0.010
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
26 |
0.010
|
|
|
|
inner ear development
|
GO:0048839 |
126 |
0.010
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
16 |
0.010
|
|
|
|
negative regulation of jun kinase activity
|
GO:0043508 |
1 |
0.010
|
|
|
|
actin filament based movement
|
GO:0030048 |
1 |
0.010
|
|
|
|
cell death in response to oxidative stress
|
GO:0036473 |
2 |
0.010
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
2 |
0.010
|
|
|
|
negative regulation of macromolecule metabolic process
|
GO:0010605 |
76 |
0.010
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
157 |
0.010
|
|
